Next Article in Journal
A Treat-and-Extend Regimen of Intravitreal Brolucizumab for Exudative Age-Related Macular Degeneration Refractory to Aflibercept: A 12-Month Result
Next Article in Special Issue
Impact of Body Mass Index in the Cardioverter Efficacy of Amiodarone in Persistent Atrial Fibrillation
Previous Article in Journal
Epigenetic Targets and Their Inhibitors in Thyroid Cancer Treatment
Previous Article in Special Issue
ABT-333 (Dasabuvir) Increases Action Potential Duration and Provokes Early Afterdepolarizations in Canine Left Ventricular Cells via Inhibition of IKr
 
 
Article

Article Versions Notes

Pharmaceuticals 2023, 16(4), 560; https://doi.org/10.3390/ph16040560
Action Date Notes Link
article xml file uploaded 7 April 2023 07:45 CEST Original file -
article xml uploaded. 7 April 2023 07:45 CEST Update https://www.mdpi.com/1424-8247/16/4/560/xml
article pdf uploaded. 7 April 2023 07:45 CEST Version of Record https://www.mdpi.com/1424-8247/16/4/560/pdf
article html file updated 7 April 2023 07:47 CEST Original file -
article html file updated 20 April 2023 20:58 CEST Update https://www.mdpi.com/1424-8247/16/4/560/html
Back to TopTop